NO964533D0 - Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser - Google Patents

Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser

Info

Publication number
NO964533D0
NO964533D0 NO964533A NO964533A NO964533D0 NO 964533 D0 NO964533 D0 NO 964533D0 NO 964533 A NO964533 A NO 964533A NO 964533 A NO964533 A NO 964533A NO 964533 D0 NO964533 D0 NO 964533D0
Authority
NO
Norway
Prior art keywords
hetero
substituted amino
antimicrobial compounds
novel quinolone
quinolone
Prior art date
Application number
NO964533A
Other languages
English (en)
Other versions
NO964533L (no
Inventor
Jr Thomas Prosser Demuth
Ronald Eugene White
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NO964533D0 publication Critical patent/NO964533D0/no
Publication of NO964533L publication Critical patent/NO964533L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
NO964533A 1994-04-28 1996-10-25 Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser NO964533L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/235,003 US5646163A (en) 1992-10-30 1994-04-28 Quinolone 5-(N-heterosubstituted amino) antimicrobials
PCT/US1995/004495 WO1995029894A1 (en) 1994-04-28 1995-04-11 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials

Publications (2)

Publication Number Publication Date
NO964533D0 true NO964533D0 (no) 1996-10-25
NO964533L NO964533L (no) 1996-12-23

Family

ID=22883653

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964533A NO964533L (no) 1994-04-28 1996-10-25 Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser

Country Status (11)

Country Link
US (1) US5646163A (no)
EP (1) EP0757675A1 (no)
JP (1) JPH09512549A (no)
KR (1) KR100244992B1 (no)
CN (1) CN1157611A (no)
AU (1) AU2246695A (no)
BR (1) BR9507553A (no)
CA (1) CA2188918A1 (no)
FI (1) FI964318A7 (no)
NO (1) NO964533L (no)
WO (1) WO1995029894A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304344B6 (cs) * 2000-09-11 2014-03-19 Novartis Vaccines & Diagnostics, Inc. Chinolinonový derivát a jeho použití a farmaceutický prostředek s obsahem tohoto derivátu
KR20060069836A (ko) * 2003-08-12 2006-06-22 아칠리온 파르마세우티칼스 인코포레이티드 항-감염제로서의 이소티아졸로퀴놀론 및 관련 화합물
CN100410249C (zh) * 2003-09-10 2008-08-13 杏林制药株式会社 7-(4-取代-3-环丙基氨基甲基-1-吡咯烷基)喹诺酮羧酸衍生物
AU2005273961A1 (en) * 2004-08-11 2006-02-23 Williamsburg Holdings Llc Noncardiotoxic pharmaceutical compounds
KR101289115B1 (ko) * 2004-08-13 2013-07-23 엠에스디 인터내셔널 홀딩즈 게엠베하 항생제인 트리아졸 및 코르티코스테로이드를 포함하는약제학적 제형
RU2349586C2 (ru) * 2004-09-17 2009-03-20 Сайлин Фармасьютикалз, Инк. Аналоги хинолона
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
EP1802306A2 (en) * 2004-09-17 2007-07-04 Cylene Pharmaceuticals, Inc. Quinolone analog as cell proliferation inhibitors
CN101120004A (zh) * 2004-11-11 2008-02-06 艾其林医药公司 用作抗感染剂的8a,9-二氢-4a-h-异噻唑[5,4-b]喹啉-3,4-二酮及相关化合物
US7659399B2 (en) * 2005-01-05 2010-02-09 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
WO2006084053A1 (en) 2005-02-02 2006-08-10 Achillion Pharmaceuticals, Inc. 8-n-substituted-2h-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
ATE491713T1 (de) * 2005-02-16 2011-01-15 Achillion Pharmaceuticals Inc Neue isothiazolochinolone und verwandte verbindungen als infektionsschutzmittel
JP5143000B2 (ja) 2005-07-27 2013-02-13 アキリオン ファーマシューティカルズ,インコーポレーテッド 抗感染症薬としての8−メトキシ−9H−イソチアゾロ[5,4−b]キノリン−3,4−ジオンおよび関連化合物
EP1928887B1 (en) * 2005-08-05 2014-12-17 Senhwa Biosciences, Inc. Methods of preparing quinolone analogs
CL2007003332A1 (es) * 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US8183236B2 (en) * 2007-04-12 2012-05-22 University Of Southern California Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
CA2688008A1 (en) * 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
EA201101451A1 (ru) * 2009-04-03 2012-03-30 Ачиллион Фармасьютикалз, Инк. Гидрокситиенохинолоны и родственные соединения как противоинфекционные средства
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
NZ599290A (en) 2009-10-16 2014-10-31 Melinta Therapeutics Inc Antimicrobial compounds and methods of making and using the same
CN108456211A (zh) * 2009-10-16 2018-08-28 梅琳塔治疗公司 抗微生物化合物和其制备和使用方法
MX2012004341A (es) 2009-10-16 2012-10-05 Rib X Pharmaceuticals Inc Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos.
EP3038623A4 (en) 2013-09-09 2017-04-19 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
CA2923214A1 (en) 2013-09-09 2015-03-12 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
HK1249758A1 (zh) 2015-03-11 2018-11-09 Melinta Therapeutics, Inc. 抗微生物化合物及其制备和使用方法
US11098047B2 (en) 2016-05-06 2021-08-24 BioVersys AG Antimicrobials and methods of making and using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4954507A (en) * 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2664950B2 (ja) * 1988-08-31 1997-10-22 日本電気株式会社 入出力処理装置
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones
KR100204987B1 (ko) * 1990-04-18 1999-06-15 제이코버스 코넬리스 레이서 항미생물성 퀴놀로닐 락탐
ES2101119T3 (es) * 1991-10-01 1997-07-01 Procter & Gamble Pharma Procedimiento para preparar quinolonil-lactamas antimicrobianas.
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Also Published As

Publication number Publication date
AU2246695A (en) 1995-11-29
FI964318A0 (fi) 1996-10-25
US5646163A (en) 1997-07-08
KR100244992B1 (ko) 2000-03-02
JPH09512549A (ja) 1997-12-16
FI964318L (fi) 1996-12-23
NO964533L (no) 1996-12-23
CN1157611A (zh) 1997-08-20
EP0757675A1 (en) 1997-02-12
WO1995029894A1 (en) 1995-11-09
BR9507553A (pt) 1997-08-05
FI964318A7 (fi) 1996-12-23
CA2188918A1 (en) 1995-11-09
KR970702849A (ko) 1997-06-10

Similar Documents

Publication Publication Date Title
NO964533D0 (no) Nye kinolon 5-(N-heterosubstituert amino) antimikrobielle forbindelser
FI971774A7 (fi) Antimikrobaalisia fenyylioksatsolidinoniyhdisteitä
FI973217A7 (fi) Heteroaromaattisella renkaalla substituoituja antimikrobiaalisia fenyylioksatsolidinoniyhdisteitä
FI971516A7 (fi) Antimikrobinen koostumus
DE69707907D1 (de) Herbizid wirkende zusammensetzung
BR9408582A (pt) Composição herbicida
NO20000226D0 (no) Nye spiroazabicykliske heterocykliske forbindelser
NO982071D0 (no) Benzoksazin-antimikrobielle midler
NO974605D0 (no) Nye heterosykliske forbindelser
FI973207A7 (fi) Heterosyklisiä yhdisteitä
ZA938089B (en) Novel antimicrobial 5-(N-heterosubstituted amino) quinolones
ATE233268T1 (de) Antibakterielle cephalosporinverbindungen
BR9508191A (pt) Composição herbicida
BR9607487A (pt) Composição herbicida
BR9407123A (pt) Composição herbicida
FI945763L (fi) Herbisidiset yhdisteet
DE69621471D1 (de) Kristalline antimikrobielle Zusammensetzung
TR27243A (tr) Antimikrobiyal proteinler.
IS4233A (is) Misleit hringtengd efnasambönd
NO981216D0 (no) Nye heterosykliske forbindelser
FI913655A7 (fi) 2-(9-fluorenonyyli)-karbapeneemi bakteerinvastaiset yhdisteet
NO965109D0 (no) Antimikrobielle sammensetninger
FI944120A7 (fi) Kinoliiniyhdisteet
FI965230A7 (fi) Bakteerinvastaisia aineita
BR9707330A (pt) Composição herbicida